HLA
KURA icon

Hamilton Lane Advisors’s Kura Oncology KURA Stock Holding History

Hamilton Lane Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-38,948
Closed -$591K – 54
2019
Q3 		$591K Buy
38,948
+28,663
+279% +$510K 0.25% 32
2019
Q2 		$203K Sell
10,285
-538
-5% -$8.93K 0.1% 46
2019
Q1 		$180K Buy
+10,823
New +$167K 0.1% 51

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Hamilton Lane Advisors's KURA Position: Q4 2019 in Review

Hamilton Lane Advisors sold out of Kura Oncology (KURA) in Q4 2019, closing a stake of 38,948 shares — an estimated $591K sold.

Hamilton Lane Advisors first reported a position in KURA in Q1 2019 and held it in 3 quarters. The position peaked at $591K in Q3 2019. 127 funds tracked by Wall St. Rank hold KURA as of Q4 2019.

  • Hamilton Lane Advisors reported no remaining Kura Oncology position as of Q4 2019 after selling out during the quarter.
  • Hamilton Lane Advisors sold 38,948 Kura Oncology shares in Q4 2019, an estimated $591K.
  • Hamilton Lane Advisors first reported a position in Kura Oncology in Q1 2019 and held it in 3 quarters.
  • Hamilton Lane Advisors's Kura Oncology position peaked at $591K in Q3 2019.
  • 127 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2019.

Based on Hamilton Lane Advisors's 13F filing for Q4 2019, filed 31 Jan 2020.